Pay in 4 interest-free payments of $7.44 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Substitution of Ala with Aib at position 8 increases enzymatic (DPP4) stability
Mechanism of Action Pancreas: Increases glucose-dependent insulin secretion, decreases glucagon Brain: Enhances satiety Stomach: Slows gastric emptying Main Indications Type 2 diabetes mellitus Obesity/weight management Cardiovascular risk reduction Common Drugs Exenatide Liraglutide Semaglutide Dulaglutide Tirzepatide (dual GIP/GLP-1 agonist) Key Benefits Significant weight loss Low hypoglycemia risk Cardiovascular protection Major Side Effects Nausea/vomiting (most common) Pancreatitis (rare) Thyroid C-cell tumors (boxed warning) Contraindications Multiple Endocrine Neoplasia type 2 (MEN2) Personal/family history of medullary thyroid carcinoma #Pharmaceuticals #GLP1 #Diabetes #Obesity #Healthcare #Biotech #ClinicalResearch #Endocrinology #MedicalAffairs To view or add a comment, sign in More Relevant Posts New Experimental Study | Diabetes & Lipid Management Can Cinnamomum zeylanicum (Ceylon cinnamon) enhance conventional therapy in diabetes
AUC differences were compared using the two-tailed DeLong method
Stay Ahead of Constipation: If you notice things slowing down, proactively increase your fiber intake (from vegetables, not just supplements) and ensure you're well-hydrated
US$ 25.05
US$ 26.41
US$ 23.23
US$ 21.19
US$ 25.05
US$ 21.90
US$ 22.52
US$ 22.81
US$ 22.66
